FIGURE 1.

In vitro simulated ischemia/reperfusion (SI/R) study protocol on H9C2 cell line (A). Somatostatin (SST) (1 nM, 10 nM, 100 nM, and 300 nM and 1 µM) or its vehicle (VEH) was added to the cells during the whole experiment. Viability of SST-treated H9C2 cells exposed to normoxia (N) (B) or SI/R (C). Data are presented as mean ± SEM. The Kruskal-Wallis test and Dunn’s post hoc test, *p < 0.05; **p < 0.01 vs. VEH from four independent experiments. RFU: relative fluorescence unit.